1255 Mrv0541 02231215212D 19 19 0 0 0 0 999 V2000 -0.8608 -0.5948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5748 -1.0081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2898 -0.5965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2907 0.2285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5768 0.6419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8618 0.2302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1478 0.6436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5671 0.2319 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.2811 0.6453 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.9961 0.2336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7101 0.6470 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 3.4250 0.2353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1390 0.6487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.8540 0.2370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.5679 0.6504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5681 -0.5931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9971 -0.5914 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.7091 1.4720 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 6.2829 0.2387 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 6 2 0 0 0 0 2 3 2 0 0 0 0 3 4 1 0 0 0 0 4 5 2 0 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 7 8 1 0 0 0 0 8 9 1 0 0 0 0 9 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 14 15 1 0 0 0 0 8 16 1 1 0 0 0 10 17 2 0 0 0 0 11 18 1 1 0 0 0 15 19 1 0 0 0 0 M END > DB01255 > drugbank > C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN > InChI=1S/C15H25N3O/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19)/t12-,14-/m0/s1 > VOBHXZCDAVEXEY-JSGCOSHPSA-N > C15H25N3O > 263.3785 > 263.199762437 > 3 > 44 > 1.9637247746838584 > 31.280962628894486 > 1 > 3 > 0 > 1 > (2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide > 1.01 > 1.135830796 > -3.48 > 0 > 2 > 1 > 2 > 15.885676132636705 > 10.21284535333755 > 81.14 > 78.3148 > 8 > 1 > 8.77e-02 g/l > tetrahydrofolic acid > 0 > DB01255 > approved; investigational > Lisdexamfetamine > Lisdexamfetamine > Lisdexamfetamine Dimesylate; Lisdexamfetamine dimesylate; Vyvanse > Lisdexamfetamine dimesylate $$$$